Chronic Myelogenous Leukemia

Research

Mayo Clinic has a longstanding interest in the treatment of CML. New drugs that inhibit the bcr-abl protein are being researched. A new research program attempting to stimulate patients' immune systems to fight leukemia is also in development at Mayo Clinic.